Observational Study of HIV-Infected Subjects With X4-Tropic or Non-Phenotypeable Virus
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00321438 |
Recruitment Status
:
Terminated
First Posted
: May 3, 2006
Last Update Posted
: May 18, 2009
|
Sponsor:
GlaxoSmithKline
Information provided by:
GlaxoSmithKline
Tracking Information | ||||
---|---|---|---|---|
First Submitted Date | May 1, 2006 | |||
First Posted Date | May 3, 2006 | |||
Last Update Posted Date | May 18, 2009 | |||
Study Start Date | July 2005 | |||
Primary Completion Date | Not Provided | |||
Current Primary Outcome Measures | Not Provided | |||
Original Primary Outcome Measures | Not Provided | |||
Change History | Complete list of historical versions of study NCT00321438 on ClinicalTrials.gov Archive Site | |||
Current Secondary Outcome Measures | Not Provided | |||
Original Secondary Outcome Measures | Not Provided | |||
Current Other Outcome Measures | Not Provided | |||
Original Other Outcome Measures | Not Provided | |||
Descriptive Information | ||||
Brief Title | Observational Study of HIV-Infected Subjects With X4-Tropic or Non-Phenotypeable Virus | |||
Official Title | Prospective, Observational Study of Subjects With CXCR4-Tropic or Non-Phenotypeable HIV to Assess Changes in Tropism Over Time | |||
Brief Summary | The purpose of this study is to measure viral tropism over time in subjects with X4-tropic or non-phenotypeable virus while receiving standard of care therapy. This is an observational study. No investigational treatment will be administered through this study. | |||
Detailed Description | Not Provided | |||
Study Type | Observational | |||
Study Design | Time Perspective: Prospective | |||
Target Follow-Up Duration | Not Provided | |||
Biospecimen | Not Provided | |||
Sampling Method | Not Provided | |||
Study Population | Not Provided | |||
Condition | HIV Infection | |||
Intervention | Not Provided | |||
Study Groups/Cohorts | Not Provided | |||
Publications * | Not Provided | |||
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
||||
Recruitment Information | ||||
Recruitment Status | Terminated | |||
Enrollment |
150 | |||
Original Enrollment | Same as current | |||
Study Completion Date | Not Provided | |||
Primary Completion Date | Not Provided | |||
Eligibility Criteria | Inclusion Criteria:
Exclusion criteria:
|
|||
Sex/Gender |
|
|||
Ages | 18 Years and older (Adult, Senior) | |||
Accepts Healthy Volunteers | No | |||
Contacts | Contact information is only displayed when the study is recruiting subjects | |||
Listed Location Countries | United States | |||
Removed Location Countries | Argentina, Australia, Austria, Belgium, Brazil, Chile, Denmark, France, Germany, Greece, Hong Kong, Hungary, India, Ireland, Israel, Italy, Malaysia, Mexico, Netherlands, Portugal, Puerto Rico, Romania, South Africa, Spain, Taiwan, United Kingdom | |||
Administrative Information | ||||
NCT Number | NCT00321438 | |||
Other Study ID Numbers | CCR104629 | |||
Has Data Monitoring Committee | Not Provided | |||
U.S. FDA-regulated Product | Not Provided | |||
IPD Sharing Statement | Not Provided | |||
Responsible Party | Study Director, GSK | |||
Study Sponsor | GlaxoSmithKline | |||
Collaborators | Not Provided | |||
Investigators |
|
|||
PRS Account | GlaxoSmithKline | |||
Verification Date | May 2009 |